Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis

Clinical and Experimental Dermatology

Volumn 29, Issue 6, 2004, Pages 633-636

  Waldman, M A ^a   Black, D R ^a   Callen, J P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; DICLOFENAC; GENTAMICIN; IMMUNOGLOBULIN A; PHENYTOIN; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CASE REPORT; DERMATITIS HERPETIFORMIS; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ERYTHEMA MULTIFORME; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; LINEAR IMMUNOGLOBULIN A BULLOUS DISEASE; MALE; MUCOUS MEMBRANE PEMPHIGOID; PEMPHIGOID; PRIORITY JOURNAL; TOXIC EPIDERMAL NECROLYSIS;

AGED; ANTI-BACTERIAL AGENTS; AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; EPIDERMAL NECROLYSIS, TOXIC; HUMANS; IMMUNOGLOBULIN A; MALE; SKIN DISEASES, VESICULOBULLOUS; VANCOMYCIN;

EID: 9644257018     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01649.x     Document Type: Article

References (12)

1. Kuechle MK, Stegemeir E, Maynard B et al. Drug-induced linear IgA bullous dermatosis: Report of six cases and review of the literature. J Am Acad Dermatol 1994; 30: 187-92.
2. Paul D, Wolkenstein P, Prost C et al. Drug-induced linear IgA disease: target antigens are heterogeneous. Br J Dermatol 1997; 136: 406-11.
3. Nousari HC, Kimayi-Asadi A, Caeiro JP, Anhalt GJ. Clinical, demographic and immunohistologic features of Vancomycin-induced linear IgA bullous disease or the skin: Report of 2 cases and review of the literature. Medicine 1999; 78: 1-8.
4. Klein PA, Callen JP. Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. J Am Acad Dermatol 2000; 42: 316-23.
5. Mofid MZ, Costarangos C, Bernstein B et al. Drug-induced Linear Immunoglobulin A Bullous Disease That Clinically Mimics Toxic Epidermal Necrolysis. J Burn Care Rehabil 2000; 21: 246-7.
6. Hughes AP, Callen JP. Drug-induced linear IgA bullous Dermatosis mimicking toxic epidermal necrolysis. Dermatology 2001; 202: 138-9.
7. Wetterwald E, Le Cleach L, Wechsler J et al. Bullous drug eruption masquerading as toxic epidermal necrolysis. Eur Recontres Hop 1999; 45: 15-8.
8. Tran D, Kossard S, Shumack S. Phenytoin-induced linear IgA dermatosis mimicking toxic epidermal necrolysis. Australas J Dermatol 2003; 44: 284-6.
9. Dellavalle RP, Burch JM, Tayal S et al. Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis. J Am Acad Dermatol 2003; 48: S56-7.
10. Ishiko A, Shimizu H, Masunaga T et al. 97 kDA linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen. J Invest Dermatol 1998; 111: 93-6.
11. Marinkovich MP, Taylor TB, Keene DR et al. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 1996; 106: 734-8.
12. Palmer RA, Ogg G, Allen J et al. Vancomycin-induced linear IgA disease with autoantibodies to BP 180 and LAD 285. Br J Dermatol 2001; 145: 816-20.